Clinical Trial Update: Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and feasibility of a three-drug combination of sunitinib with S-1 and cisplatin in gastric cancer (stomach neoplasms).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Platinol (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Stomach Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2015-03-13